First Trust NYSE Arca Biotechnology Index Fund
224 hedge funds and large institutions have $588M invested in First Trust NYSE Arca Biotechnology Index Fund in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 45 increasing their positions, 85 reducing their positions, and 18 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
33% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 18
2% more funds holding
Funds holding: 220 → 224 (+4)
1.28% more ownership
Funds ownership: 44.84% → 46.12% (+1.3%)
11% less capital invested
Capital invested by funds: $663M → $588M (-$74.8M)
47% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 85
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$8.05M |
| 2 |
SMF
Sterling Manor Financial
Saratoga Springs,
New York
|
+$4.87M |
| 3 |
MIG
McGuire Investment Group
Wakefield,
Rhode Island
|
+$4.02M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.85M |
| 5 |
MML Investors Services
Springfield,
Massachusetts
|
+$1.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$12.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$5.73M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$4.67M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3.12M |
| 5 |
LPL Financial
San Diego,
California
|
-$2.8M |
FBT Hedge Fund Activity: Q2 2022 in Review
224 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q2 2022, worth a combined $588M — down 11% from $663M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new FBT positions and 18 closed out — a net gain of 6 holders — while 45 added to existing stakes and 85 trimmed.
The largest buyer was Osaic Holdings, adding an estimated $8.05M. The largest seller was Morgan Stanley, cutting an estimated $12.5M.
- 224 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q2 2022, up from 220 in Q1 2022.
- Funds reported $588M of First Trust NYSE Arca Biotechnology Index Fund stock for Q2 2022, down 11% quarter-over-quarter.
- 24 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q2 2022 and 18 closed out, a net change of +6 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q2 2022 was Osaic Holdings, an estimated $8.05M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q2 2022 was Morgan Stanley, an estimated $12.5M sold.
Based on aggregated 13F filings for Q2 2022.